Skip to main content
HCWB
NASDAQ Life Sciences

HCW Biologics Q2 Loss Widens to $5.2M; Going Concern Warning Issued

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$2.66
Mkt Cap
$4.248M
52W Low
$1.5
52W High
$44.1
52W Position info
77% above low
Off High info
94% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

HCWB sits 77% above its 52-week low of $1.5 on light trading volume (0.1× avg).

Summary

HCW Biologics' Q2 loss widened to $5.2 million and the company warned of substantial doubt about its ability to continue as a going concern, with only $741,324 in cash.


Key Events · Earnings and Guidance · HCWB

  • Q2 Loss Widens

    Net loss of $5.2 million for Q2 2026, compared to $1.9 million in Q2 2025.

  • Going Concern Warning

    Management expressed substantial doubt about the company's ability to continue as a going concern for at least 12 months.

  • Cash Position

    Cash and cash equivalents of $741,324 as of June 30, 2026, down from $1.95 million at year-end 2025.

  • Internal Control Weaknesses

    Two material weaknesses in internal controls remain unremediated, including one related to warrant accounting.


Analysis · HCWB · Life Sciences

The second quarter of 2026 brought a net loss of $5.2 million, more than double the $1.9 million loss reported a year earlier. With only $741,324 in cash as of June 30, 2026, management has expressed substantial doubt about the company's ability to continue as a going concern. Material weaknesses in internal controls also remain unremediated. A $1.6 million private placement closed on July 29, 2026, with insider participation, but the cash runway remains extremely tight.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HCWB was trading at $2.66 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.2M. The 52-week trading range was $1.50 to $44.10. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HCWB - Latest Insights

HCWB
Nov 18, 2026, 5:24 PM EST
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.7639
Real-time Price: $0.720 info
Change: -$0.0439 (-6%) info
Market Cap: $2.308M info
HCWB
Nov 16, 2026, 8:30 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.780
Real-time Price: $0.720 info
Change: -$0.060 (-8%) info
Market Cap: $2.308M info
HCWB
Nov 16, 2026, 8:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.780
Real-time Price: $0.720 info
Change: -$0.060 (-8%) info
Market Cap: $2.308M info
HCWB
Nov 16, 2026, 8:15 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.780
Real-time Price: $0.720 info
Change: -$0.060 (-8%) info
Market Cap: $2.308M info
HCWB
Nov 05, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.09
Real-time Price: $0.720 info
Change: -$0.370 (-34%) info
Market Cap: $2.308M info